Huang Y - Search Results

1

Programmed drug delivery system based on optimized "size decrease and hydrophilicity/hydrophobicity transformation" for enhanced hepatocellular carcinoma therapy of doxorubicin.

Liu Y, Li L, Li L, Zhou Z, Wang F, Xiong X, Zhou R, Huang Y. Liu Y, et al. Among authors: huang y. Nanomedicine. 2018 Jun;14(4):1111-1122. doi: 10.1016/j.nano.2018.02.006. Epub 2018 Feb 17. Nanomedicine. 2018. PMID: 29458212

2

Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells.

Xiang Q, Yang Y, Zhou Z, Zhou D, Jin Y, Zhang Z, Huang Y. Xiang Q, et al. Among authors: huang y. Eur J Pharm Biopharm. 2012 Feb;80(2):379-86. doi: 10.1016/j.ejpb.2011.10.020. Epub 2011 Nov 12. Eur J Pharm Biopharm. 2012. PMID: 22101181

3

Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.

Yang Y, Zhou Z, He S, Fan T, Jin Y, Zhu X, Chen C, Zhang ZR, Huang Y. Yang Y, et al. Among authors: huang y. Biomaterials. 2012 Mar;33(7):2260-71. doi: 10.1016/j.biomaterials.2011.12.007. Epub 2011 Dec 19. Biomaterials. 2012. PMID: 22189143

4

Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.

Chen C, Fan T, Jin Y, Zhou Z, Yang Y, Zhu X, Zhang ZR, Zhang Q, Huang Y. Chen C, et al. Among authors: huang y. Nanomedicine (Lond). 2013 Jul;8(7):1085-100. doi: 10.2217/nnm.12.141. Epub 2012 Oct 17. Nanomedicine (Lond). 2013. PMID: 23075315

5

Investigation of the mechanisms of improved oral bioavailability of bergenin using bergenin-phospholipid complex.

Guan S, Qin X, Zhou Z, Zhang Q, Huang Y. Guan S, et al. Among authors: huang y. Drug Dev Ind Pharm. 2014 Feb;40(2):163-71. doi: 10.3109/03639045.2012.752500. Epub 2013 Jan 15. Drug Dev Ind Pharm. 2014. PMID: 23317338

6

Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers.

Zhao C, Fan T, Yang Y, Wu M, Li L, Zhou Z, Jian Y, Zhang Q, Huang Y. Zhao C, et al. Among authors: huang y. Int J Pharm. 2013 Jun 25;450(1-2):11-20. doi: 10.1016/j.ijpharm.2013.04.030. Epub 2013 Apr 20. Int J Pharm. 2013. PMID: 23612355

7

Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery.

Zhu X, Shan W, Zhang P, Jin Y, Guan S, Fan T, Yang Y, Zhou Z, Huang Y. Zhu X, et al. Among authors: huang y. Mol Pharm. 2014 Jan 6;11(1):317-28. doi: 10.1021/mp400493b. Epub 2013 Nov 25. Mol Pharm. 2014. PMID: 24255985

8

Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.

Li L, Yang Q, Zhou Z, Zhong J, Huang Y. Li L, et al. Among authors: huang y. Biomaterials. 2014 Jun;35(19):5171-87. doi: 10.1016/j.biomaterials.2014.03.027. Epub 2014 Apr 1. Biomaterials. 2014. PMID: 24702960

9

Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.

Zhou Z, Li L, Yang Y, Xu X, Huang Y. Zhou Z, et al. Among authors: huang y. Biomaterials. 2014 Aug;35(24):6622-35. doi: 10.1016/j.biomaterials.2014.04.059. Epub 2014 May 10. Biomaterials. 2014. PMID: 24814427

10

Comparison of active and passive targeting of doxorubicin for somatostatin receptor 2 positive tumor models by octreotide-modified HPMA copolymer-doxorubicin conjugates.

He S, Zhou Z, Li L, Yang Q, Yang Y, Guan S, Zhang J, Zhu X, Jin Y, Huang Y. He S, et al. Among authors: huang y. Drug Deliv. 2016;23(1):285-96. doi: 10.3109/10717544.2014.911991. Epub 2014 May 28. Drug Deliv. 2016. PMID: 24865288 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,050 results

Search Page

Filters